文献速递医学教育与科研方法临床试验与 GCP

临床试验中保留策略的规划——对试验团队成员的一项定性访谈研究

Planning retention strategies in clinical trials-a qualitative interview study with members of trial teams.
PubMed 文献 · J Clin Epidemiol · 2025-09-19

该研究通过一对一半结构化访谈,调查英国和爱尔兰的24名试验人员如何在临床试验中规划参与者保留策略。结果显示,保留策略多在试验设计与方案开发阶段前瞻性制定,若保留率出现问题则反应性补充策略;策略选择主要由核心试验管理团队依据既往经验决定,正式与非正式策略均被认为重要。作者认为需要对策略有效性进行更正式的评估,以促进循证决策。

要点

  • 保留策略多在试验设计与方案开发阶段前瞻性规划,保留率不佳时再反应性补充。
  • 策略选择主要由核心试验管理团队依据既往使用经验决定。
  • 正式策略(如提醒、激励)与非正式策略(如建立融洽关系、积极投入的试验人员)均被认为有助于保留。

核心结论

  • 多数试验人员在前瞻性规划并实施保留策略,同时也会对试验进行中出现的保留率不佳做出反应。
  • 目前保留策略的选择基于既往使用该策略的经验,需要对有效性进行更正式的评估以促进循证决策。

研究设计与样本

  • 采用一对一半结构化访谈,以线上或面对面方式进行,访谈对象为英国和爱尔兰的试验人员。
  • 采用目的性滚雪球抽样招募受访者,共访谈24名试验人员,包括试验经理、研究协调员、主要研究者、研究护士、试验运营主管、临床试验部门主任、临床试验监查员、共同研究者和临床试验从业者。
  • 数据分析采用框架分析法,以识别不同试验人员群体内部及群体之间数据模式的异同。

主要发现

  • 保留策略的制定多在试验设计与方案开发阶段前瞻性完成。
  • 参与者保留是一个持续过程,若保留率出现问题,则反应性规划并实施额外策略。
  • 策略倾向于由核心试验管理团队选择,选择主要依据既往经验。
  • 使用多种正式策略(明确且有意规划、通常更有结构的策略,如提醒或激励)以促进持续的参与者保留。
  • 非正式策略(未明确或有意规划),如与参与者建立融洽关系以及拥有积极投入的试验人员,也被强调对促进试验保留很重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To address poor participant retention, trial teams often use retention strategies. Evidence on the planning of retention strategies in trials is limited. Based on our previously conducted research, and other existing literature, it is unclear whether retention strategies are prospectively or retrospectively planned by trialists. Our objective was to investigate this. STUDY DESIGN AND SETTING: One-to-one semistructured interviews, online or in person, were conducted with trialists in the United Kingdom and Ireland to gain better insights into planning retention strategies across various trialists viewpoints. Purposive snowball sampling was used to recruit interviewees. Data were analyzed using framework analysis. This approach was chosen to aid in identifying similarities and differences in patterns in the data within and between different groups of trialists interviewed, for example, Trial Managers, Research Nurses, Principal Investigators etc. RESULTS: Twenty-four trialists were interviewed, including trial managers, study co-ordinators, principal investigators, research nurses, a head of trial operations, a clinical trial unit director, a clinical trial monitor, a co-investigator, and a clinical trials practitioner. Findings show that the development of retention strategies in trials is mostly done proactively during the design and planning stages of the trial, that is, during trial design and protocol development. Participant retention, however, is an ongoing process, and if retention rates are problematic, additional strategies are reactively planned and implemented. Strategies tend to be chosen by the core trial management team, and the choice of strategy is mainly guided by prior experience. A variety of different formal strategies (explicitly and intentionally planned strategies that are often more structured, such as reminders or incentives) are used to facilitate ongoing participant retention. Informal strategies (not explicitly or intentionally planned), such as building rapport with participants and having motivated and invested trial staff, are also highlighted as being important to facilitating retention in trials. CONCLUSION: Most trialists proactively plan and implement retention strategies during the design and planning stages of the trial but are also responsive to poor retention rates as the trial is ongoing. Currently, retention strategies are chosen based on prior experience of using the strategy. More formal evaluation of effectiveness is needed to help facilitate evidence-based decision-making when choosing retention strategies.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Murphy E, McCann S, Shiely F, et al. Planning retention strategies in clinical trials-a qualitative interview study with members of trial teams. J Clin Epidemiol. 2025. PMID: 40976518. doi:10.1016/j.jclinepi.2025.111979

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。